ANRO Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues Investment in Pipeline CCEP Q4 2018 Earnings Modest EPS Miss Amidst Quiet Quarter SLSR Q1 2026 Earnings Narrowing Losses Despite Market Headwinds YALA Q1 2026 Earnings EPS of 016 Highlights Solid Performance Amid Limited Disclosures RRC Q1 2026 Earnings EPS Surges Past Estimates with 19 Beat Amid Strategic Operations BEAM Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response